AARP Hearing Center
Key takeaways
- Fewer stand-alone Part D plans than previous years.
- Prescription drug coverage secure in original Medicare.
- Medicare Advantage prescription coverage is stable.
- Consumer-friendly legislation revamped Part D coverage.
- Use Medicare open enrollment to compare drug plans.
Medicare’s market for Part D plans has shifted in response to growing enrollment in private Medicare Advantage plans, and the number of stand-alone prescription drug plans available to original Medicare beneficiaries continues to decline in 2026.
In 2020, 53 percent of Part D enrollees were enrolled in stand-alone Part D drug plans used by beneficiaries in original Medicare. By 2025, only 42 percent of Part D enrollees were in stand-alone drug plans, while 58 percent received Part D coverage through their Medicare Advantage plans.
The number of plans is decreasing amid rising drug prices, a law that shifted more Part D costs to plan sponsors and drug companies, and the emergence of Medicare Advantage as the program’s dominant — and better financed — coverage vehicle.
This year, the average original Medicare beneficiary can choose from 14 stand-alone drug plans, the fewest since the Part D program began in 2006. Next year, the overall number of plans available nationwide will drop by almost a quarter to 360, down from 464 in 2025 and 709 in 2024, according to KFF.
By contrast, the average Medicare Advantage enrollee can select from 32 plans that include drug coverage. This, too, is a slight decline from 2025.
Part D coverage choices remain strong
Despite the changes, beneficiaries will still have plenty of Part D plan options. Depending on where you live, beneficiaries in each state still can choose among eight to 12 stand-alone drug plans for 2026 coverage during Medicare open enrollment, which runs through Dec. 7, says Juliette Cubanski, deputy director of the Program on Medicare Policy at KFF. The nonprofit health care research organization has offices in Washington.
“Enrollees still have plenty of choice,” she says. “By almost any measure, in any other marketplace, having eight or 10 or 12 [plans] to choose from is still a relatively robust set of offerings.”
More than 35.3 million people, 51.2 percent of eligible Medicare beneficiaries, receive coverage through private Medicare Advantage plans from commercial insurers and other health plans. Along with medical coverage, nearly all Medicare Advantage plans also cover prescription drugs.
Roughly 33.7 million people — 48.8 percent of beneficiaries — are in original Medicare. Of those, about 23 million get their Part D coverage through stand-alone drug plans. Many of the same insurers that sell Medicare Advantage coverage also sell the separate plans.
“They just make more money when they’ve got somebody enrolled in their Medicare Advantage plan than when they’ve got somebody enrolled in their stand-alone drug plans” because of the way the federal government pays for Medicare Advantage plans, Cubanski says.
AARP has long called for greater efficiency and value in payments to Medicare Advantage plans. “We have also championed ensuring consumers have a robust choice of both traditional Medicare and MA [Medicare Advantage] coverage, striving to keep both options strong and on a level playing field,” said a March 2024 letter to the Centers for Medicare & Medicaid Services.
More From AARP
7 Ways to Avoid Paying Higher Medicare Premiums
Certain life events can exempt enrollees from surcharges
10 Surprising Things That Medicare Doesn’t Cover
You should plan to pay for some common medical expenses
Medicare Drug Price Cuts Will Save Billions
Lower costs on 15 meds include Ozempic, related drugs